GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (OTCPK:DTXMF) » Definitions » EV-to-EBIT

Deltex Medical Group (Deltex Medical Group) EV-to-EBIT : -3.43 (As of Jun. 02, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Deltex Medical Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Deltex Medical Group's Enterprise Value is $4.56 Mil. Deltex Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.33 Mil. Therefore, Deltex Medical Group's EV-to-EBIT for today is -3.43.

The historical rank and industry rank for Deltex Medical Group's EV-to-EBIT or its related term are showing as below:

DTXMF' s EV-to-EBIT Range Over the Past 10 Years
Min: -290.77   Med: -6.44   Max: -1.9
Current: -3.41

During the past 13 years, the highest EV-to-EBIT of Deltex Medical Group was -1.90. The lowest was -290.77. And the median was -6.44.

DTXMF's EV-to-EBIT is ranked worse than
100% of 450 companies
in the Medical Devices & Instruments industry
Industry Median: 19.65 vs DTXMF: -3.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Deltex Medical Group's Enterprise Value for the quarter that ended in Dec. 2023 was $3.76 Mil. Deltex Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.33 Mil. Deltex Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -35.44%.


Deltex Medical Group EV-to-EBIT Historical Data

The historical data trend for Deltex Medical Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group EV-to-EBIT Chart

Deltex Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -213.87 -13.76 -12.18 -9.11 -3.56

Deltex Medical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.18 - -9.11 - -3.56

Competitive Comparison of Deltex Medical Group's EV-to-EBIT

For the Medical Devices subindustry, Deltex Medical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deltex Medical Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Deltex Medical Group's EV-to-EBIT falls into.



Deltex Medical Group EV-to-EBIT Calculation

Deltex Medical Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.564/-1.331
=-3.43

Deltex Medical Group's current Enterprise Value is $4.56 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Deltex Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltex Medical Group  (OTCPK:DTXMF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Deltex Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-1.331/3.755645
=-35.44 %

Deltex Medical Group's Enterprise Value for the quarter that ended in Dec. 2023 was $3.76 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Deltex Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltex Medical Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltex Medical Group (Deltex Medical Group) Business Description

Traded in Other Exchanges
Address
Terminus Road, Chichester, W Sussex, GBR, PO19 8TX
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (Deltex Medical Group) Headlines

No Headlines